StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday
Immutep downgraded to speculative hold from speculative buy at Bell Potter (A$0.06, 0.00)
Street Takeaways - Immutep discontinued TACTI-004 Phase III study (A$0.06, +0.01)
Immutep downgraded to hold from buy at Maxim Group ($0.48, 0.00)
Immutep downgraded to neutral from outperform at Baird ($2.76, 0.00)
Immutep downgraded to market perform from market outperform at Citizens ($2.76, 0.00)
Powered by FactSet Research Systems Inc.